Registration

ARNOLD & PORTER KAYE SCHOLER LLP for IPSEN BIOPHARMACEUTICALS INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to FDA oversight.

LobbyistCovered position, as disclosed
KRISTINE BLACKWOOD New 4/10-6/15:DepDir,ConOversight,HHS;1/09-4/10: ChfCon, Sen.Com.Aging; 1/7-12/08: InvestigCon,House Energy&Commerce Com.; 6/05-1/07: USDOJ Of Leg. Affairs; 11/03-06/05: HealthCareFraud Coord,ExecOff,US Attys,USDOJ; 6/94-11/03: Asst. US Atty,CenDistrCA
KEVIN MICHAEL O'NEILL New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
IPSEN GROUP France France 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.